Logo

CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 401k Plan overview

Plan NameCLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN
Plan identification number 001

CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Participant-directed brokerage accounts provided as an investment option under the plan.
  • Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
  • Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

CLINICAL REFERENCE LABORATORY, INC. has sponsored the creation of one or more 401k plans.

Company Name:CLINICAL REFERENCE LABORATORY, INC.
Employer identification number (EIN):480964521
NAIC Classification:621510
NAIC Description: Medical and Diagnostic Laboratories

Form 5500 Filing Information

Submission information for form 5500 for 401k plan CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0012021-01-01
0012021-01-01EILEEN KEARNEY
0012020-01-01
0012019-01-01
0012018-01-01EILEEN KEARNEY
0012017-01-01EILEEN KEARNEY
0012016-01-01EILEEN KEARNEY
0012015-01-01EILEEN
0012014-01-01EILEEN KEARNEY
0012013-01-01EILEEN KEARNEY
0012012-01-01EILEEN KEARNEY
0012011-01-01EILEEN KEARNEY
0012010-01-01EILEEN KEARNEY
0012009-01-01
0012009-01-01EILEEN KEARNEY EILEEN KEARNEY2010-06-18

Plan Statistics for CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN

401k plan membership statisitcs for CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN

Measure Date Value
2021: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year2021-01-01786
Total number of active participants reported on line 7a of the Form 55002021-01-010
Number of retired or separated participants receiving benefits2021-01-010
Number of other retired or separated participants entitled to future benefits2021-01-010
Total of all active and inactive participants2021-01-010
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2021-01-010
Total participants2021-01-010
Number of participants with account balances2021-01-010
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2021-01-0152
2020: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year2020-01-01786
Total number of active participants reported on line 7a of the Form 55002020-01-01648
Number of retired or separated participants receiving benefits2020-01-013
Number of other retired or separated participants entitled to future benefits2020-01-01118
Total of all active and inactive participants2020-01-01769
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2020-01-010
Total participants2020-01-01769
Number of participants with account balances2020-01-01652
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2020-01-0124
2019: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year2019-01-01786
Total number of active participants reported on line 7a of the Form 55002019-01-01679
Number of retired or separated participants receiving benefits2019-01-011
Number of other retired or separated participants entitled to future benefits2019-01-0197
Total of all active and inactive participants2019-01-01777
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2019-01-010
Total participants2019-01-01777
Number of participants with account balances2019-01-01620
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2019-01-0116
2018: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year2018-01-01773
Total number of active participants reported on line 7a of the Form 55002018-01-01698
Number of retired or separated participants receiving benefits2018-01-010
Number of other retired or separated participants entitled to future benefits2018-01-0175
Total of all active and inactive participants2018-01-01773
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2018-01-010
Total participants2018-01-01773
Number of participants with account balances2018-01-01538
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2018-01-018
2017: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year2017-01-01680
Total number of active participants reported on line 7a of the Form 55002017-01-01679
Number of retired or separated participants receiving benefits2017-01-010
Number of other retired or separated participants entitled to future benefits2017-01-0181
Total of all active and inactive participants2017-01-01760
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2017-01-010
Total participants2017-01-01760
Number of participants with account balances2017-01-01540
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2017-01-0120
2016: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year2016-01-01678
Total number of active participants reported on line 7a of the Form 55002016-01-01578
Number of retired or separated participants receiving benefits2016-01-010
Number of other retired or separated participants entitled to future benefits2016-01-0150
Total of all active and inactive participants2016-01-01628
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2016-01-010
Total participants2016-01-01628
Number of participants with account balances2016-01-01504
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2016-01-0113
2015: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year2015-01-01571
Total number of active participants reported on line 7a of the Form 55002015-01-01540
Number of retired or separated participants receiving benefits2015-01-010
Number of other retired or separated participants entitled to future benefits2015-01-0164
Total of all active and inactive participants2015-01-01604
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2015-01-010
Total participants2015-01-01604
Number of participants with account balances2015-01-01511
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2015-01-0110
2014: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year2014-01-01471
Total number of active participants reported on line 7a of the Form 55002014-01-01433
Number of retired or separated participants receiving benefits2014-01-010
Number of other retired or separated participants entitled to future benefits2014-01-0160
Total of all active and inactive participants2014-01-01493
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2014-01-010
Total participants2014-01-01493
Number of participants with account balances2014-01-01460
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2014-01-0120
2013: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year2013-01-01506
Total number of active participants reported on line 7a of the Form 55002013-01-01391
Number of retired or separated participants receiving benefits2013-01-010
Number of other retired or separated participants entitled to future benefits2013-01-0157
Total of all active and inactive participants2013-01-01448
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2013-01-010
Total participants2013-01-01448
Number of participants with account balances2013-01-01405
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2013-01-0124
2012: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year2012-01-01535
Total number of active participants reported on line 7a of the Form 55002012-01-01408
Number of retired or separated participants receiving benefits2012-01-010
Number of other retired or separated participants entitled to future benefits2012-01-0162
Total of all active and inactive participants2012-01-01470
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2012-01-010
Total participants2012-01-01470
Number of participants with account balances2012-01-01418
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2012-01-0130
2011: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2011 401k membership
Total participants, beginning-of-year2011-01-01498
Total number of active participants reported on line 7a of the Form 55002011-01-01403
Number of retired or separated participants receiving benefits2011-01-010
Number of other retired or separated participants entitled to future benefits2011-01-0189
Total of all active and inactive participants2011-01-01492
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2011-01-010
Total participants2011-01-01492
Number of participants with account balances2011-01-01445
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2011-01-0132
2010: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2010 401k membership
Total participants, beginning-of-year2010-01-01517
Total number of active participants reported on line 7a of the Form 55002010-01-01376
Number of retired or separated participants receiving benefits2010-01-010
Number of other retired or separated participants entitled to future benefits2010-01-0184
Total of all active and inactive participants2010-01-01460
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2010-01-010
Total participants2010-01-01460
Number of participants with account balances2010-01-01412
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2010-01-0128
2009: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year2009-01-01532
Total number of active participants reported on line 7a of the Form 55002009-01-01409
Number of retired or separated participants receiving benefits2009-01-010
Number of other retired or separated participants entitled to future benefits2009-01-0196
Total of all active and inactive participants2009-01-01505
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2009-01-010
Total participants2009-01-01505
Number of participants with account balances2009-01-01447
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2009-01-0146

Financial Data on CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN

Measure Date Value
2021 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets2021-12-31$0
Total transfer of assets from this plan2021-12-31$49,480,460
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total income from all sources (including contributions)2021-12-31$11,005,265
Total loss/gain on sale of assets2021-12-31$0
Total of all expenses incurred2021-12-31$3,473,823
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$3,219,572
Value of total corrective distributions2021-12-31$17,207
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$5,295,019
Value of total assets at end of year2021-12-31$0
Value of total assets at beginning of year2021-12-31$41,949,018
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$237,044
Total interest from all sources2021-12-31$255,838
Total dividends received (eg from common stock, registered investment company shares)2021-12-31$700,500
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2021-12-31$700,500
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$1,000,000
If this is an individual account plan, was there a blackout period2021-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2021-12-31$0
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$3,427,865
Participant contributions at end of year2021-12-31$0
Participant contributions at beginning of year2021-12-31$413,277
Assets. Other investments not covered elsewhere at end of year2021-12-31$0
Assets. Other investments not covered elsewhere at beginning of year2021-12-31$66,185
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$797,841
Other income not declared elsewhere2021-12-31$56,142
Administrative expenses (other) incurred2021-12-31$237,044
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Value of net income/loss2021-12-31$7,531,442
Value of net assets at end of year (total assets less liabilities)2021-12-31$0
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$41,949,018
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2021-12-31$20,119,465
Value of interest in pooled separate accounts at end of year2021-12-31$0
Value of interest in pooled separate accounts at beginning of year2021-12-31$13,660,389
Interest on participant loans2021-12-31$26,476
Interest earned on other investments2021-12-31$229,362
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2021-12-31$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2021-12-31$7,689,702
Net investment gain/loss from registered investment companies (e.g. mutual funds)2021-12-31$1,417,228
Net investment gain/loss from pooled separate accounts2021-12-31$3,280,538
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31No
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Contributions received in cash from employer2021-12-31$1,069,313
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$3,219,572
Did the plan have assets held for investment2021-12-31No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31Yes
Opinion of an independent qualified public accountant for this plan2021-12-31Unqualified
Accountancy firm name2021-12-31MAYER HOFFMAN MCCANN PC
Accountancy firm EIN2021-12-31431947695
2020 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets2020-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total income from all sources (including contributions)2020-12-31$8,702,492
Total loss/gain on sale of assets2020-12-31$0
Total of all expenses incurred2020-12-31$5,604,986
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2020-12-31$5,396,309
Value of total corrective distributions2020-12-31$8,843
Total contributions o plan (from employers,participants, others, non cash contrinutions)2020-12-31$3,660,319
Value of total assets at end of year2020-12-31$41,949,018
Value of total assets at beginning of year2020-12-31$38,851,512
Total of administrative expenses incurred including professional, contract, advisory and management fees2020-12-31$199,834
Total interest from all sources2020-12-31$230,065
Total dividends received (eg from common stock, registered investment company shares)2020-12-31$270,536
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2020-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2020-12-31$270,536
Was this plan covered by a fidelity bond2020-12-31Yes
Value of fidelity bond cover2020-12-31$1,000,000
If this is an individual account plan, was there a blackout period2020-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2020-12-31$0
Were there any nonexempt tranactions with any party-in-interest2020-12-31No
Contributions received from participants2020-12-31$2,677,268
Participant contributions at end of year2020-12-31$413,277
Participant contributions at beginning of year2020-12-31$376,516
Assets. Other investments not covered elsewhere at end of year2020-12-31$66,185
Assets. Other investments not covered elsewhere at beginning of year2020-12-31$62,308
Income. Received or receivable in cash from other sources (including rollovers)2020-12-31$180,574
Other income not declared elsewhere2020-12-31$52,305
Administrative expenses (other) incurred2020-12-31$199,834
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Value of net income/loss2020-12-31$3,097,506
Value of net assets at end of year (total assets less liabilities)2020-12-31$41,949,018
Value of net assets at beginning of year (total assets less liabilities)2020-12-31$38,851,512
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2020-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2020-12-31No
Were any leases to which the plan was party in default or uncollectible2020-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2020-12-31$20,119,465
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2020-12-31$19,718,572
Value of interest in pooled separate accounts at end of year2020-12-31$13,660,389
Value of interest in pooled separate accounts at beginning of year2020-12-31$12,216,671
Interest on participant loans2020-12-31$24,066
Interest earned on other investments2020-12-31$205,999
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2020-12-31$7,689,702
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2020-12-31$6,477,445
Net investment gain/loss from registered investment companies (e.g. mutual funds)2020-12-31$2,071,438
Net investment gain/loss from pooled separate accounts2020-12-31$2,417,829
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2020-12-31No
Was there a failure to transmit to the plan any participant contributions2020-12-31No
Has the plan failed to provide any benefit when due under the plan2020-12-31No
Contributions received in cash from employer2020-12-31$802,477
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2020-12-31$5,396,309
Did the plan have assets held for investment2020-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2020-12-31No
Opinion of an independent qualified public accountant for this plan2020-12-31Unqualified
Accountancy firm name2020-12-31MAYER HOFFMAN MCCANN PC
Accountancy firm EIN2020-12-31431947695
2019 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total income from all sources (including contributions)2019-12-31$10,350,914
Total loss/gain on sale of assets2019-12-31$0
Total of all expenses incurred2019-12-31$2,512,331
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$2,317,352
Value of total corrective distributions2019-12-31$15,771
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$3,626,636
Value of total assets at end of year2019-12-31$38,851,512
Value of total assets at beginning of year2019-12-31$31,012,929
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$179,208
Total interest from all sources2019-12-31$196,036
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$352,797
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$352,797
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$1,000,000
If this is an individual account plan, was there a blackout period2019-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2019-12-31$0
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$2,709,647
Participant contributions at end of year2019-12-31$376,516
Participant contributions at beginning of year2019-12-31$484,703
Assets. Other investments not covered elsewhere at end of year2019-12-31$62,308
Assets. Other investments not covered elsewhere at beginning of year2019-12-31$61,738
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$147,995
Other income not declared elsewhere2019-12-31$45,821
Administrative expenses (other) incurred2019-12-31$179,208
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$7,838,583
Value of net assets at end of year (total assets less liabilities)2019-12-31$38,851,512
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$31,012,929
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$19,718,572
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$15,768,019
Value of interest in pooled separate accounts at end of year2019-12-31$12,216,671
Value of interest in pooled separate accounts at beginning of year2019-12-31$9,554,817
Interest on participant loans2019-12-31$26,961
Interest earned on other investments2019-12-31$169,075
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2019-12-31$6,477,445
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2019-12-31$5,143,652
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$3,478,661
Net investment gain/loss from pooled separate accounts2019-12-31$2,650,963
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31Yes
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$768,994
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$2,317,352
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31MAYER HOFFMAN MCCANN PC
Accountancy firm EIN2019-12-31431947695
2018 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets2018-12-31$0
Total transfer of assets from this plan2018-12-31$1,468,516
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total income from all sources (including contributions)2018-12-31$1,944,002
Total loss/gain on sale of assets2018-12-31$0
Total of all expenses incurred2018-12-31$3,776,993
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2018-12-31$3,568,838
Value of total corrective distributions2018-12-31$37,429
Total contributions o plan (from employers,participants, others, non cash contrinutions)2018-12-31$3,508,045
Value of total assets at end of year2018-12-31$31,012,929
Value of total assets at beginning of year2018-12-31$34,314,436
Total of administrative expenses incurred including professional, contract, advisory and management fees2018-12-31$170,726
Total interest from all sources2018-12-31$177,456
Total dividends received (eg from common stock, registered investment company shares)2018-12-31$343,472
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2018-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2018-12-31$343,472
Was this plan covered by a fidelity bond2018-12-31Yes
Value of fidelity bond cover2018-12-31$1,000,000
If this is an individual account plan, was there a blackout period2018-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2018-12-31$0
Were there any nonexempt tranactions with any party-in-interest2018-12-31No
Contributions received from participants2018-12-31$2,470,499
Participant contributions at end of year2018-12-31$484,703
Participant contributions at beginning of year2018-12-31$483,605
Assets. Other investments not covered elsewhere at end of year2018-12-31$61,738
Assets. Other investments not covered elsewhere at beginning of year2018-12-31$61,967
Income. Received or receivable in cash from other sources (including rollovers)2018-12-31$327,787
Other income not declared elsewhere2018-12-31$50,279
Administrative expenses (other) incurred2018-12-31$170,726
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Value of net income/loss2018-12-31$-1,832,991
Value of net assets at end of year (total assets less liabilities)2018-12-31$31,012,929
Value of net assets at beginning of year (total assets less liabilities)2018-12-31$34,314,436
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2018-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2018-12-31No
Were any leases to which the plan was party in default or uncollectible2018-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2018-12-31$15,768,019
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2018-12-31$18,515,874
Value of interest in pooled separate accounts at end of year2018-12-31$9,554,817
Value of interest in pooled separate accounts at beginning of year2018-12-31$10,054,058
Interest on participant loans2018-12-31$28,750
Interest earned on other investments2018-12-31$148,706
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2018-12-31$5,143,652
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2018-12-31$5,198,932
Net investment gain/loss from registered investment companies (e.g. mutual funds)2018-12-31$-1,837,840
Net investment gain/loss from pooled separate accounts2018-12-31$-297,410
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2018-12-31No
Was there a failure to transmit to the plan any participant contributions2018-12-31Yes
Has the plan failed to provide any benefit when due under the plan2018-12-31No
Contributions received in cash from employer2018-12-31$709,759
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2018-12-31$3,568,838
Did the plan have assets held for investment2018-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2018-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2018-12-31Yes
Opinion of an independent qualified public accountant for this plan2018-12-31Disclaimer
Accountancy firm name2018-12-31MAYER HOFFMAN MCCANN PC
Accountancy firm EIN2018-12-31431947695
2017 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets2017-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total income from all sources (including contributions)2017-12-31$9,047,336
Total loss/gain on sale of assets2017-12-31$0
Total of all expenses incurred2017-12-31$4,558,297
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2017-12-31$4,402,260
Value of total corrective distributions2017-12-31$3,483
Total contributions o plan (from employers,participants, others, non cash contrinutions)2017-12-31$3,922,384
Value of total assets at end of year2017-12-31$34,314,436
Value of total assets at beginning of year2017-12-31$29,825,397
Total of administrative expenses incurred including professional, contract, advisory and management fees2017-12-31$152,554
Total interest from all sources2017-12-31$192,562
Total dividends received (eg from common stock, registered investment company shares)2017-12-31$295,690
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2017-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2017-12-31$295,690
Was this plan covered by a fidelity bond2017-12-31Yes
Value of fidelity bond cover2017-12-31$1,000,000
If this is an individual account plan, was there a blackout period2017-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2017-12-31$0
Were there any nonexempt tranactions with any party-in-interest2017-12-31No
Contributions received from participants2017-12-31$2,952,559
Participant contributions at end of year2017-12-31$483,605
Participant contributions at beginning of year2017-12-31$546,779
Assets. Other investments not covered elsewhere at end of year2017-12-31$61,967
Assets. Other investments not covered elsewhere at beginning of year2017-12-31$186,635
Income. Received or receivable in cash from other sources (including rollovers)2017-12-31$151,574
Other income not declared elsewhere2017-12-31$39,715
Administrative expenses (other) incurred2017-12-31$152,554
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Value of net income/loss2017-12-31$4,489,039
Value of net assets at end of year (total assets less liabilities)2017-12-31$34,314,436
Value of net assets at beginning of year (total assets less liabilities)2017-12-31$29,825,397
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2017-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2017-12-31No
Were any leases to which the plan was party in default or uncollectible2017-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2017-12-31$18,515,874
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2017-12-31$15,905,585
Value of interest in pooled separate accounts at end of year2017-12-31$10,054,058
Value of interest in pooled separate accounts at beginning of year2017-12-31$8,169,422
Interest on participant loans2017-12-31$28,608
Interest earned on other investments2017-12-31$163,954
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2017-12-31$5,198,932
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2017-12-31$5,016,976
Net investment gain/loss from registered investment companies (e.g. mutual funds)2017-12-31$2,765,255
Net investment gain/loss from pooled separate accounts2017-12-31$1,831,730
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2017-12-31No
Was there a failure to transmit to the plan any participant contributions2017-12-31No
Has the plan failed to provide any benefit when due under the plan2017-12-31No
Contributions received in cash from employer2017-12-31$818,251
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2017-12-31$4,402,260
Did the plan have assets held for investment2017-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2017-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2017-12-31Yes
Opinion of an independent qualified public accountant for this plan2017-12-31Disclaimer
Accountancy firm name2017-12-31MAYER HOFFMAN MCCANN PC
Accountancy firm EIN2017-12-31431947695
2016 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets2016-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total income from all sources (including contributions)2016-12-31$4,646,470
Total loss/gain on sale of assets2016-12-31$0
Total of all expenses incurred2016-12-31$1,846,313
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2016-12-31$1,781,772
Expenses. Certain deemed distributions of participant loans2016-12-31$-1,500
Value of total corrective distributions2016-12-31$12,082
Total contributions o plan (from employers,participants, others, non cash contrinutions)2016-12-31$3,058,991
Value of total assets at end of year2016-12-31$29,825,397
Value of total assets at beginning of year2016-12-31$27,025,240
Total of administrative expenses incurred including professional, contract, advisory and management fees2016-12-31$53,959
Total interest from all sources2016-12-31$157,615
Total dividends received (eg from common stock, registered investment company shares)2016-12-31$211,202
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2016-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2016-12-31$211,202
Was this plan covered by a fidelity bond2016-12-31Yes
Value of fidelity bond cover2016-12-31$1,000,000
If this is an individual account plan, was there a blackout period2016-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2016-12-31$0
Were there any nonexempt tranactions with any party-in-interest2016-12-31No
Contributions received from participants2016-12-31$2,457,796
Participant contributions at end of year2016-12-31$546,779
Participant contributions at beginning of year2016-12-31$189,493
Assets. Other investments not covered elsewhere at end of year2016-12-31$186,635
Assets. Other investments not covered elsewhere at beginning of year2016-12-31$173,583
Income. Received or receivable in cash from other sources (including rollovers)2016-12-31$69,256
Other income not declared elsewhere2016-12-31$71,537
Administrative expenses (other) incurred2016-12-31$53,959
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Value of net income/loss2016-12-31$2,800,157
Value of net assets at end of year (total assets less liabilities)2016-12-31$29,825,397
Value of net assets at beginning of year (total assets less liabilities)2016-12-31$27,025,240
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2016-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2016-12-31No
Were any leases to which the plan was party in default or uncollectible2016-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2016-12-31$15,905,585
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2016-12-31$22,178,649
Value of interest in pooled separate accounts at end of year2016-12-31$8,169,422
Value of interest in pooled separate accounts at beginning of year2016-12-31$0
Interest on participant loans2016-12-31$15,465
Interest earned on other investments2016-12-31$142,150
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2016-12-31$5,016,976
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2016-12-31$4,483,515
Net investment gain/loss from registered investment companies (e.g. mutual funds)2016-12-31$1,024,464
Net investment gain/loss from pooled separate accounts2016-12-31$122,661
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2016-12-31No
Was there a failure to transmit to the plan any participant contributions2016-12-31No
Has the plan failed to provide any benefit when due under the plan2016-12-31No
Contributions received in cash from employer2016-12-31$531,939
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2016-12-31$1,781,772
Did the plan have assets held for investment2016-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2016-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2016-12-31Yes
Opinion of an independent qualified public accountant for this plan2016-12-31Disclaimer
Accountancy firm name2016-12-31MAYER HOFFMAN MCCANN PC
Accountancy firm EIN2016-12-31431947695
2015 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets2015-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total income from all sources (including contributions)2015-12-31$3,070,083
Total loss/gain on sale of assets2015-12-31$0
Total of all expenses incurred2015-12-31$1,838,083
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2015-12-31$1,795,388
Expenses. Certain deemed distributions of participant loans2015-12-31$1,500
Value of total corrective distributions2015-12-31$3,359
Total contributions o plan (from employers,participants, others, non cash contrinutions)2015-12-31$2,703,525
Value of total assets at end of year2015-12-31$27,025,240
Value of total assets at beginning of year2015-12-31$25,793,240
Total of administrative expenses incurred including professional, contract, advisory and management fees2015-12-31$37,836
Total interest from all sources2015-12-31$128,376
Total dividends received (eg from common stock, registered investment company shares)2015-12-31$236,293
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2015-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2015-12-31$236,293
Was this plan covered by a fidelity bond2015-12-31Yes
Value of fidelity bond cover2015-12-31$1,000,000
If this is an individual account plan, was there a blackout period2015-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2015-12-31$0
Were there any nonexempt tranactions with any party-in-interest2015-12-31No
Contributions received from participants2015-12-31$2,180,876
Participant contributions at end of year2015-12-31$189,493
Participant contributions at beginning of year2015-12-31$147,333
Assets. Other investments not covered elsewhere at end of year2015-12-31$173,583
Assets. Other investments not covered elsewhere at beginning of year2015-12-31$175,967
Income. Received or receivable in cash from other sources (including rollovers)2015-12-31$25,881
Other income not declared elsewhere2015-12-31$51,797
Administrative expenses (other) incurred2015-12-31$37,836
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Value of net income/loss2015-12-31$1,232,000
Value of net assets at end of year (total assets less liabilities)2015-12-31$27,025,240
Value of net assets at beginning of year (total assets less liabilities)2015-12-31$25,793,240
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2015-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2015-12-31No
Were any leases to which the plan was party in default or uncollectible2015-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2015-12-31$22,178,649
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2015-12-31$21,171,515
Interest on participant loans2015-12-31$8,673
Interest earned on other investments2015-12-31$119,668
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2015-12-31$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2015-12-31$631,267
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2015-12-31$631,267
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2015-12-31$35
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2015-12-31$4,483,515
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2015-12-31$3,667,158
Net investment gain/loss from registered investment companies (e.g. mutual funds)2015-12-31$-49,908
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2015-12-31No
Was there a failure to transmit to the plan any participant contributions2015-12-31Yes
Has the plan failed to provide any benefit when due under the plan2015-12-31No
Contributions received in cash from employer2015-12-31$496,768
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2015-12-31$1,795,388
Did the plan have assets held for investment2015-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2015-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2015-12-31Yes
Opinion of an independent qualified public accountant for this plan2015-12-31Disclaimer
Accountancy firm name2015-12-31MAYER HOFFMAN MCCANN PC
Accountancy firm EIN2015-12-31431947695
2014 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets2014-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total income from all sources (including contributions)2014-12-31$3,152,993
Total loss/gain on sale of assets2014-12-31$0
Total of all expenses incurred2014-12-31$2,104,262
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2014-12-31$2,098,940
Value of total corrective distributions2014-12-31$721
Total contributions o plan (from employers,participants, others, non cash contrinutions)2014-12-31$2,340,194
Value of total assets at end of year2014-12-31$25,793,240
Value of total assets at beginning of year2014-12-31$24,744,509
Total of administrative expenses incurred including professional, contract, advisory and management fees2014-12-31$4,601
Total interest from all sources2014-12-31$112,821
Total dividends received (eg from common stock, registered investment company shares)2014-12-31$305,079
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2014-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2014-12-31$305,079
Was this plan covered by a fidelity bond2014-12-31Yes
Value of fidelity bond cover2014-12-31$1,000,000
If this is an individual account plan, was there a blackout period2014-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2014-12-31$0
Were there any nonexempt tranactions with any party-in-interest2014-12-31No
Contributions received from participants2014-12-31$1,690,378
Participant contributions at end of year2014-12-31$147,333
Participant contributions at beginning of year2014-12-31$132,998
Assets. Other investments not covered elsewhere at end of year2014-12-31$175,967
Assets. Other investments not covered elsewhere at beginning of year2014-12-31$502,533
Income. Received or receivable in cash from other sources (including rollovers)2014-12-31$251,096
Other income not declared elsewhere2014-12-31$-4,661
Administrative expenses (other) incurred2014-12-31$4,601
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Value of net income/loss2014-12-31$1,048,731
Value of net assets at end of year (total assets less liabilities)2014-12-31$25,793,240
Value of net assets at beginning of year (total assets less liabilities)2014-12-31$24,744,509
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2014-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2014-12-31No
Were any leases to which the plan was party in default or uncollectible2014-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2014-12-31$21,171,515
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2014-12-31$19,914,816
Interest on participant loans2014-12-31$7,708
Interest earned on other investments2014-12-31$105,051
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2014-12-31$631,267
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2014-12-31$706,925
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2014-12-31$706,925
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2014-12-31$62
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2014-12-31$3,667,158
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2014-12-31$3,487,237
Net investment gain/loss from registered investment companies (e.g. mutual funds)2014-12-31$399,560
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2014-12-31No
Was there a failure to transmit to the plan any participant contributions2014-12-31No
Has the plan failed to provide any benefit when due under the plan2014-12-31No
Contributions received in cash from employer2014-12-31$398,720
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2014-12-31$2,098,940
Did the plan have assets held for investment2014-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2014-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2014-12-31Yes
Opinion of an independent qualified public accountant for this plan2014-12-31Disclaimer
Accountancy firm name2014-12-31MAYER HOFFMAN MCCANN PC
Accountancy firm EIN2014-12-31431947695
2013 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets2013-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total income from all sources (including contributions)2013-12-31$6,210,440
Total loss/gain on sale of assets2013-12-31$0
Total of all expenses incurred2013-12-31$1,635,225
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$1,623,133
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$1,882,043
Value of total assets at end of year2013-12-31$24,744,509
Value of total assets at beginning of year2013-12-31$20,169,294
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$12,092
Total interest from all sources2013-12-31$93,831
Total dividends received (eg from common stock, registered investment company shares)2013-12-31$214,463
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2013-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2013-12-31$214,463
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$1,000,000
If this is an individual account plan, was there a blackout period2013-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2013-12-31$0
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$1,508,172
Participant contributions at end of year2013-12-31$132,998
Participant contributions at beginning of year2013-12-31$162,049
Assets. Other investments not covered elsewhere at end of year2013-12-31$502,533
Assets. Other investments not covered elsewhere at beginning of year2013-12-31$466,945
Income. Received or receivable in cash from other sources (including rollovers)2013-12-31$16,073
Other income not declared elsewhere2013-12-31$35,568
Administrative expenses (other) incurred2013-12-31$12,092
Total non interest bearing cash at beginning of year2013-12-31$578
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$4,575,215
Value of net assets at end of year (total assets less liabilities)2013-12-31$24,744,509
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$20,169,294
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2013-12-31$19,914,816
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2013-12-31$16,614,709
Interest on participant loans2013-12-31$7,805
Interest earned on other investments2013-12-31$85,981
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2013-12-31$706,925
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2013-12-31$505,730
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2013-12-31$505,730
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2013-12-31$45
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2013-12-31$3,487,237
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2013-12-31$2,419,283
Net investment gain/loss from registered investment companies (e.g. mutual funds)2013-12-31$3,984,535
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31No
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Contributions received in cash from employer2013-12-31$357,798
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$1,623,133
Did the plan have assets held for investment2013-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2013-12-31Yes
Opinion of an independent qualified public accountant for this plan2013-12-31Disclaimer
Accountancy firm name2013-12-31MAYER HOFFMAN MCCANN PC
Accountancy firm EIN2013-12-31431947695
2012 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets2012-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total income from all sources (including contributions)2012-12-31$4,261,652
Total loss/gain on sale of assets2012-12-31$0
Total of all expenses incurred2012-12-31$1,761,085
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2012-12-31$1,747,323
Value of total corrective distributions2012-12-31$271
Total contributions o plan (from employers,participants, others, non cash contrinutions)2012-12-31$1,873,643
Value of total assets at end of year2012-12-31$20,169,294
Value of total assets at beginning of year2012-12-31$17,668,727
Total of administrative expenses incurred including professional, contract, advisory and management fees2012-12-31$13,491
Total interest from all sources2012-12-31$79,188
Total dividends received (eg from common stock, registered investment company shares)2012-12-31$228,974
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2012-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2012-12-31$228,974
Was this plan covered by a fidelity bond2012-12-31Yes
Value of fidelity bond cover2012-12-31$1,000,000
If this is an individual account plan, was there a blackout period2012-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2012-12-31$0
Were there any nonexempt tranactions with any party-in-interest2012-12-31No
Contributions received from participants2012-12-31$1,426,109
Participant contributions at end of year2012-12-31$162,049
Participant contributions at beginning of year2012-12-31$185,686
Assets. Other investments not covered elsewhere at end of year2012-12-31$466,945
Assets. Other investments not covered elsewhere at beginning of year2012-12-31$417,747
Income. Received or receivable in cash from other sources (including rollovers)2012-12-31$89,547
Other income not declared elsewhere2012-12-31$28,801
Administrative expenses (other) incurred2012-12-31$13,491
Total non interest bearing cash at end of year2012-12-31$578
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Value of net income/loss2012-12-31$2,500,567
Value of net assets at end of year (total assets less liabilities)2012-12-31$20,169,294
Value of net assets at beginning of year (total assets less liabilities)2012-12-31$17,668,727
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2012-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2012-12-31No
Were any leases to which the plan was party in default or uncollectible2012-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2012-12-31$16,614,709
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2012-12-31$13,858,179
Interest on participant loans2012-12-31$9,590
Interest earned on other investments2012-12-31$69,579
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2012-12-31$505,730
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2012-12-31$452,917
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2012-12-31$452,917
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2012-12-31$19
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2012-12-31$2,419,283
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2012-12-31$2,754,198
Net investment gain/loss from registered investment companies (e.g. mutual funds)2012-12-31$2,051,046
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2012-12-31No
Was there a failure to transmit to the plan any participant contributions2012-12-31No
Has the plan failed to provide any benefit when due under the plan2012-12-31No
Contributions received in cash from employer2012-12-31$357,987
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2012-12-31$1,747,323
Did the plan have assets held for investment2012-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2012-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2012-12-31Yes
Opinion of an independent qualified public accountant for this plan2012-12-31Disclaimer
Accountancy firm name2012-12-31MAYER HOFFMAN MCCANN PC
Accountancy firm EIN2012-12-31431947695
2011 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2011 401k financial data
Total unrealized appreciation/depreciation of assets2011-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total income from all sources (including contributions)2011-12-31$1,263,421
Total loss/gain on sale of assets2011-12-31$0
Total of all expenses incurred2011-12-31$809,613
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2011-12-31$803,581
Total contributions o plan (from employers,participants, others, non cash contrinutions)2011-12-31$1,673,427
Value of total assets at end of year2011-12-31$17,668,727
Value of total assets at beginning of year2011-12-31$17,214,919
Total of administrative expenses incurred including professional, contract, advisory and management fees2011-12-31$6,032
Total interest from all sources2011-12-31$94,820
Total dividends received (eg from common stock, registered investment company shares)2011-12-31$242,513
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2011-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2011-12-31$242,513
Was this plan covered by a fidelity bond2011-12-31Yes
Value of fidelity bond cover2011-12-31$1,000,000
If this is an individual account plan, was there a blackout period2011-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2011-12-31$0
Were there any nonexempt tranactions with any party-in-interest2011-12-31No
Contributions received from participants2011-12-31$1,399,910
Participant contributions at end of year2011-12-31$185,686
Participant contributions at beginning of year2011-12-31$258,079
Assets. Other investments not covered elsewhere at end of year2011-12-31$417,747
Assets. Other investments not covered elsewhere at beginning of year2011-12-31$397,523
Other income not declared elsewhere2011-12-31$-11,759
Administrative expenses (other) incurred2011-12-31$6,032
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Value of net income/loss2011-12-31$453,808
Value of net assets at end of year (total assets less liabilities)2011-12-31$17,668,727
Value of net assets at beginning of year (total assets less liabilities)2011-12-31$17,214,919
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2011-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2011-12-31No
Were any leases to which the plan was party in default or uncollectible2011-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2011-12-31$13,858,179
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2011-12-31$13,391,461
Interest on participant loans2011-12-31$12,970
Interest earned on other investments2011-12-31$81,801
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2011-12-31$452,917
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2011-12-31$440,676
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2011-12-31$440,676
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2011-12-31$49
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2011-12-31$2,754,198
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2011-12-31$2,727,180
Net investment gain/loss from registered investment companies (e.g. mutual funds)2011-12-31$-735,580
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2011-12-31No
Was there a failure to transmit to the plan any participant contributions2011-12-31No
Has the plan failed to provide any benefit when due under the plan2011-12-31No
Contributions received in cash from employer2011-12-31$273,517
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2011-12-31$803,581
Did the plan have assets held for investment2011-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2011-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2011-12-31Yes
Opinion of an independent qualified public accountant for this plan2011-12-31Disclaimer
Accountancy firm name2011-12-31MAYER HOFFMAN MCCANN
Accountancy firm EIN2011-12-31431947695
2010 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets2010-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$0
Total income from all sources (including contributions)2010-12-31$3,192,622
Total loss/gain on sale of assets2010-12-31$0
Total of all expenses incurred2010-12-31$910,760
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2010-12-31$891,428
Value of total corrective distributions2010-12-31$5,517
Total contributions o plan (from employers,participants, others, non cash contrinutions)2010-12-31$1,496,509
Value of total assets at end of year2010-12-31$17,214,919
Value of total assets at beginning of year2010-12-31$14,933,057
Total of administrative expenses incurred including professional, contract, advisory and management fees2010-12-31$13,815
Total interest from all sources2010-12-31$98,629
Total dividends received (eg from common stock, registered investment company shares)2010-12-31$187,203
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2010-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2010-12-31$187,203
Was this plan covered by a fidelity bond2010-12-31Yes
Value of fidelity bond cover2010-12-31$1,000,000
If this is an individual account plan, was there a blackout period2010-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2010-12-31$0
Were there any nonexempt tranactions with any party-in-interest2010-12-31No
Contributions received from participants2010-12-31$1,347,949
Participant contributions at end of year2010-12-31$258,079
Participant contributions at beginning of year2010-12-31$240,926
Assets. Other investments not covered elsewhere at end of year2010-12-31$397,523
Assets. Other investments not covered elsewhere at beginning of year2010-12-31$413,174
Other income not declared elsewhere2010-12-31$-15,722
Administrative expenses (other) incurred2010-12-31$13,815
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Value of net income/loss2010-12-31$2,281,862
Value of net assets at end of year (total assets less liabilities)2010-12-31$17,214,919
Value of net assets at beginning of year (total assets less liabilities)2010-12-31$14,933,057
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2010-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2010-12-31No
Were any leases to which the plan was party in default or uncollectible2010-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2010-12-31$13,391,461
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2010-12-31$11,402,725
Interest on participant loans2010-12-31$16,771
Interest earned on other investments2010-12-31$81,785
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2010-12-31$440,676
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2010-12-31$398,336
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2010-12-31$398,336
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2010-12-31$73
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2010-12-31$2,727,180
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2010-12-31$2,477,896
Net investment gain/loss from registered investment companies (e.g. mutual funds)2010-12-31$1,426,003
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2010-12-31No
Was there a failure to transmit to the plan any participant contributions2010-12-31No
Has the plan failed to provide any benefit when due under the plan2010-12-31No
Contributions received in cash from employer2010-12-31$148,560
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2010-12-31$891,428
Did the plan have assets held for investment2010-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2010-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2010-12-31Yes
Opinion of an independent qualified public accountant for this plan2010-12-31Disclaimer
Accountancy firm name2010-12-31MAYER HOFFMAN MCCANN P.C.
Accountancy firm EIN2010-12-31431947695
2009 : CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2009-12-31$0

Form 5500 Responses for CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN

2021: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01Submission has been amendedNo
2021-01-01This submission is the final filingYes
2021-01-01This return/report is a short plan year return/report (less than 12 months)No
2021-01-01Plan is a collectively bargained planNo
2021-01-01Plan funding arrangement – InsuranceYes
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement – InsuranceYes
2021-01-01Plan benefit arrangement - TrustYes
2020: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2020 form 5500 responses
2020-01-01Type of plan entitySingle employer plan
2020-01-01Submission has been amendedNo
2020-01-01This submission is the final filingNo
2020-01-01This return/report is a short plan year return/report (less than 12 months)No
2020-01-01Plan is a collectively bargained planNo
2020-01-01Plan funding arrangement – InsuranceYes
2020-01-01Plan funding arrangement – TrustYes
2020-01-01Plan benefit arrangement – InsuranceYes
2020-01-01Plan benefit arrangement - TrustYes
2019: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Submission has been amendedNo
2019-01-01This submission is the final filingNo
2019-01-01This return/report is a short plan year return/report (less than 12 months)No
2019-01-01Plan is a collectively bargained planNo
2019-01-01Plan funding arrangement – InsuranceYes
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement – InsuranceYes
2019-01-01Plan benefit arrangement - TrustYes
2018: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2018 form 5500 responses
2018-01-01Type of plan entitySingle employer plan
2018-01-01Submission has been amendedNo
2018-01-01This submission is the final filingNo
2018-01-01This return/report is a short plan year return/report (less than 12 months)No
2018-01-01Plan is a collectively bargained planNo
2018-01-01Plan funding arrangement – InsuranceYes
2018-01-01Plan funding arrangement – TrustYes
2018-01-01Plan benefit arrangement – InsuranceYes
2018-01-01Plan benefit arrangement - TrustYes
2017: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2017 form 5500 responses
2017-01-01Type of plan entityMulitple employer plan
2017-01-01Submission has been amendedNo
2017-01-01This submission is the final filingNo
2017-01-01This return/report is a short plan year return/report (less than 12 months)No
2017-01-01Plan is a collectively bargained planNo
2017-01-01Plan funding arrangement – InsuranceYes
2017-01-01Plan funding arrangement – TrustYes
2017-01-01Plan benefit arrangement – InsuranceYes
2017-01-01Plan benefit arrangement - TrustYes
2016: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2016 form 5500 responses
2016-01-01Type of plan entitySingle employer plan
2016-01-01Submission has been amendedNo
2016-01-01This submission is the final filingNo
2016-01-01This return/report is a short plan year return/report (less than 12 months)No
2016-01-01Plan is a collectively bargained planNo
2016-01-01Plan funding arrangement – InsuranceYes
2016-01-01Plan funding arrangement – TrustYes
2016-01-01Plan benefit arrangement – InsuranceYes
2016-01-01Plan benefit arrangement - TrustYes
2015: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2015 form 5500 responses
2015-01-01Type of plan entitySingle employer plan
2015-01-01Submission has been amendedNo
2015-01-01This submission is the final filingNo
2015-01-01This return/report is a short plan year return/report (less than 12 months)No
2015-01-01Plan is a collectively bargained planNo
2015-01-01Plan funding arrangement – InsuranceYes
2015-01-01Plan funding arrangement – TrustYes
2015-01-01Plan benefit arrangement – InsuranceYes
2015-01-01Plan benefit arrangement - TrustYes
2014: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2014 form 5500 responses
2014-01-01Type of plan entitySingle employer plan
2014-01-01Submission has been amendedNo
2014-01-01This submission is the final filingNo
2014-01-01This return/report is a short plan year return/report (less than 12 months)No
2014-01-01Plan is a collectively bargained planNo
2014-01-01Plan funding arrangement – InsuranceYes
2014-01-01Plan funding arrangement – TrustYes
2014-01-01Plan benefit arrangement – InsuranceYes
2014-01-01Plan benefit arrangement - TrustYes
2013: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2013 form 5500 responses
2013-01-01Type of plan entitySingle employer plan
2013-01-01Submission has been amendedYes
2013-01-01This submission is the final filingNo
2013-01-01This return/report is a short plan year return/report (less than 12 months)No
2013-01-01Plan is a collectively bargained planNo
2013-01-01Plan funding arrangement – InsuranceYes
2013-01-01Plan funding arrangement – TrustYes
2013-01-01Plan benefit arrangement – InsuranceYes
2013-01-01Plan benefit arrangement - TrustYes
2012: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2012 form 5500 responses
2012-01-01Type of plan entitySingle employer plan
2012-01-01Submission has been amendedNo
2012-01-01This submission is the final filingNo
2012-01-01This return/report is a short plan year return/report (less than 12 months)No
2012-01-01Plan is a collectively bargained planNo
2012-01-01Plan funding arrangement – InsuranceYes
2012-01-01Plan funding arrangement – TrustYes
2012-01-01Plan benefit arrangement – InsuranceYes
2012-01-01Plan benefit arrangement - TrustYes
2011: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Submission has been amendedNo
2011-01-01This submission is the final filingNo
2011-01-01This return/report is a short plan year return/report (less than 12 months)No
2011-01-01Plan is a collectively bargained planNo
2011-01-01Plan funding arrangement – InsuranceYes
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement – InsuranceYes
2011-01-01Plan benefit arrangement - TrustYes
2010: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2010 form 5500 responses
2010-01-01Type of plan entitySingle employer plan
2010-01-01Submission has been amendedNo
2010-01-01This submission is the final filingNo
2010-01-01This return/report is a short plan year return/report (less than 12 months)No
2010-01-01Plan is a collectively bargained planNo
2010-01-01Plan funding arrangement – InsuranceYes
2010-01-01Plan funding arrangement – TrustYes
2010-01-01Plan benefit arrangement – InsuranceYes
2010-01-01Plan benefit arrangement - TrustYes
2009: CLINICAL REFERENCE LABORATORY, INC. PROFIT SHARING 401(K) PLAN 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01Submission has been amendedNo
2009-01-01This submission is the final filingNo
2009-01-01This return/report is a short plan year return/report (less than 12 months)No
2009-01-01Plan is a collectively bargained planNo
2009-01-01Plan funding arrangement – InsuranceYes
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement – InsuranceYes
2009-01-01Plan benefit arrangement - TrustYes

Insurance Providers Used on plan

PRUDENTIAL ANNUITIES SERVICE (National Association of Insurance Commissioners NAIC id number: 68241 )
Policy contract number007739
Policy instance 1
PRUDENTIAL ANNUITIES SERVICE (National Association of Insurance Commissioners NAIC id number: 68241 )
Policy contract number007739
Policy instance 1
PRUDENTIAL ANNUITIES SERVICE (National Association of Insurance Commissioners NAIC id number: 68241 )
Policy contract number007739
Policy instance 1
PRUDENTIAL ANNUITIES SERVICE (National Association of Insurance Commissioners NAIC id number: 68241 )
Policy contract numberGA-007739
Policy instance 1
PRUDENTIAL ANNUITIES SERVICE (National Association of Insurance Commissioners NAIC id number: 68241 )
Policy contract numberGA-007739
Policy instance 1

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
US 401k Lookup     VAT Lookup